Patent · US Active

Modulators of complement activity

US10328115B2 · kind B2 · utility

10Cited by

55References

22Claims

0Family size

Assignee

RA PHARMACEUTICALS, INC. · US

Inventors

Michelle Denise Hoarty · Billerica, US
Ketki Ashok Dhamnaskar · Foster City, US
Daniel Elbaum · Newton, US
Kristopher Josephson · Wayland, US
Kelley Cronin Larson · Quincy, US
Zhong Ma · Lexington, US
Nathan Ezekiel Nims · Winchester, US
Alonso Ricardo · Cambridge, US
Kathleen Seyb · Wakefield, US
Guo-Qing Tang · Durham, US
Douglas A. Treco · Arlington, US
Zhaolin Wang · Wellesley, US
Ping Ye · Lexington, US
Hong Zheng · New York, US
Sarah Jacqueline Perlmutter · Urbana, US

Key dates

Filing date	Feb 26, 2018
Grant date	Jun 25, 2019
Priority date	—
Expiry date	Feb 26, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides polypeptide modulators of complement activity, including cyclic polypeptide modulators. Also provided are methods of utilizing such modulators as therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.